Want to see AU:MCP full AI Analyst Report?
Mcpherson'S Limited (MCP) AI Stock Analysis
Top Page
Mcpherson'S Limited
(ASX:MCP)
The score is driven primarily by weak financial performance—multi-year revenue decline, persistent losses, and fading cash generation—partly offset by reduced debt and manageable leverage. Technicals also weigh on the score with the stock trading below key moving averages and negative MACD. Valuation offers limited support given the negative P/E and no dividend yield data.
Mcpherson'S Limited (MCP) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 18.71M
- Dividend Yield
- ―
- Average Volume (3M)
- 203.75K
- Price to Earnings (P/E)
- -0.9
- Beta (1Y)
- 0.53
- Revenue Growth
- -14.87%
- EPS Growth
- -35.60%
- Country
- Australia
- Employees
- 876
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Household & Personal Products
Mcpherson'S Limited Business Overview & Revenue Model
Company Description
McPherson's Limited is a company dedicated to distributing a wide array of health, beauty, and personal care products across Australia, New Zealand, Asia, and international markets. Their extensive portfolio includes cosmetics, haircare solutions, sk...
How the Company Makes Money
McPherson’s makes money primarily by selling branded consumer products through retail and wholesale channels. Revenue is generated when the company supplies its owned (and/or distributed) brands to retailers and other customers, with earnings driven...
Mcpherson'S Limited Financial Statement Overview
Summary
Financial performance is weak: revenue has declined for multiple years and profitability deteriorated from a small profit (FY2022) to sizable losses through FY2026, with negative operating earnings/EBITDA recently. Balance sheet leverage is improved with debt reduced materially, but equity and assets have shrunk significantly. Cash flow has weakened, with operating cash flow fading and free cash flow turning slightly negative in FY2026.
Income Statement
24NegativeBalance Sheet
58NeutralCash Flow
45Neutral| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 118.31M | 118.31M | 138.99M | 144.63M | 155.23M | 214.00M |
| Gross Profit | 39.72M | 39.72M | 80.45M | 35.09M | 47.77M | 90.80M |
| EBITDA | -663.00K | -663.00K | -3.51M | -4.92M | 3.10M | 7.44M |
| Net Income | -20.26M | -20.26M | -15.04M | -15.99M | -5.06M | 333.00K |
Balance Sheet | ||||||
| Total Assets | 96.91M | 96.91M | 117.21M | 146.90M | 190.06M | 215.76M |
| Cash, Cash Equivalents and Short-Term Investments | 5.11M | 5.11M | 9.48M | 24.77M | 7.03M | 13.14M |
| Total Debt | 6.19M | 6.19M | 7.30M | 19.85M | 25.45M | 29.38M |
| Total Liabilities | 45.14M | 45.14M | 44.23M | 57.26M | 80.61M | 94.95M |
| Stockholders Equity | 51.77M | 51.77M | 72.98M | 89.64M | 109.45M | 120.81M |
Cash Flow | ||||||
| Free Cash Flow | -49.00K | -49.00K | 1.57M | 9.64M | 4.70M | 16.32M |
| Operating Cash Flow | 675.00K | 675.00K | 2.21M | 12.34M | 6.55M | 18.57M |
| Investing Cash Flow | -1.29M | -1.29M | -3.62M | 16.29M | -1.85M | -2.25M |
| Financing Cash Flow | -3.78M | -3.78M | -13.91M | -10.90M | -10.91M | -10.59M |
Mcpherson'S Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MCP, the sentiment is Negative. The current price of 0.13 is below the 20-day moving average (MA) of 0.14, below the 50-day MA of 0.13, and below the 200-day MA of 0.15, indicating a bearish trend. The MACD of 0.00 indicates Positive momentum. The RSI at 41.12 is Neutral, neither overbought nor oversold. The STOCH value of 6.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MCP.
Mcpherson'S Limited Peers Comparison
Overall Rating
AU:NUC46Neutral
AU:ZNO45Neutral- AU:MCP43Neutral
AU:PTL41Neutral
AU:SKN37Underperform
AU:HCT29Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| AU:NUC | 46Neutral | AUD 12.55M | -1.68 | -88.51% | ― | 11.96% | -81.99% |
| AU:ZNO | 45Neutral | AUD 21.33M | -11.75 | -50.40% | ― | 28.77% | 59.60% |
| AU:MCP | 43Neutral | AUD 18.71M | -0.89 | -33.14% | ― | -14.87% | -35.60% |
| AU:PTL | 41Neutral | AUD 3.92M | -1.09 | -43.04% | ― | -29.84% | 22.51% |
| AU:SKN | 37Underperform | AUD 6.97M | -0.44 | -430.23% | ― | -50.64% | -72.00% |
| AU:HCT | 29Underperform | AUD 12.14M | -3.79 | 1795.70% | ― | 0.72% | -486.96% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:MCP | Mcpherson'S Limited | 0.13 | -0.11 | -46.94% | |
| AU:PTL | Pental Ltd. | 0.02 | -0.03 | -52.08% | |
| AU:ZNO | Zoono Group Limited | 0.05 | -0.00 | -4.08% | |
| AU:SKN | Skin Elements Limited | ― | ― | ― | |
| AU:NUC | Nuchev Pty Ltd | 0.08 | -0.06 | -42.86% | |
| AU:HCT | Holista Colltech Limited | 0.03 | -0.04 | -57.69% |
Mcpherson'S Limited Corporate Events
McPherson’s Withdraws CEO Performance Rights Resolution Ahead of AGM
McPherson’s Limited has withdrawn a resolution from its upcoming Annual General Meeting that proposed issuing performance rights to outgoing Chief Executive Officer and Managing Director Brett Charlton under the company’s Performance Righ...
McPherson’s Sets Hybrid 2026 AGM and Releases Annual Report to Shareholders
McPherson’s Limited, a Sydney-based ASX-listed supplier of essential health and beauty products, builds its business around a portfolio of established brands such as Manicare, Swisspers, Lady Jayne, Maseur, Glam, Dr. LeWinn’s and Fusion H...
McPherson’s Continues On-Market Share Buy-Back Program
McPherson’s Limited has continued its on-market share buy-back program, reporting a daily update to the ASX for its ordinary fully paid shares under code MCP. The latest notification follows the original buy-back announcement made in February 2...
McPherson’s Performance Rights Lapse Reduces Potential Share Issuance
McPherson’s Limited has announced that 3,827,536 performance rights, trading under the ASX code MCPAJ, have lapsed. These conditional rights to securities ceased because the specified conditions were not met or became incapable of being satisfi...
McPherson’s Faces Court Declarations Over Disclosure Breaches
McPherson’s Limited has announced that the Federal Court of Australia has made declarations and orders in proceedings brought by the Australian Securities and Investments Commission regarding the company’s continuous disclosure obligation...
McPherson’s Details Basis of FY26 Financial Results and Reporting Metrics
McPherson’s Limited has released its FY26 financial results presentation, outlining key performance measures and the basis of its reporting to the market. The company explains that the information is general in nature, current as at the present...
McPherson’s Sets Date for FY26 Results and Investor Briefing
McPherson’s Limited has scheduled the release of its full-year results for the 12 months to 30 June 2026 on 27 August 2026, offering investors a key update on the performance of its health and beauty portfolio. The company will host a conferenc...
McPherson’s Requests Trading Halt Ahead of ASIC Court Decision
McPherson’s Limited has requested an immediate trading halt in its securities on the ASX, effective prior to the commencement of trading on 13 August 2026. The halt is sought in accordance with ASX Listing Rule 17.1, reflecting the company̵...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 28, 2026